CD8A and cancer: PD-1+CD8+ T cells characterized by impaired effector function are frequently observed in the setting of chronic infection and malignant tumors (33, 34), but our results suggest that memory PD-1hiCD8+ T cells in RASF, in concert with CD4+ T cells, play an active role in the pathogenesis of RA.